𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Interferon-βin patients with low-grade astrocytomas — A phase I study

✍ Scribed by U. Bogdahn; B. Fleischer; J. Hilfenhaus; H. J. Röthig; P. Krauseneck; H. G. Mertens; H. Przuntek

Publisher
Springer US
Year
1985
Tongue
English
Weight
345 KB
Volume
3
Category
Article
ISSN
0167-594X

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Low expression of p27 indicates a poor p
Low expression of p27 indicates a poor prognosis in patients with high-grade astrocytomas
✍ Ruut M. Kirla; Hannu K. Haapasalo; Hannu Kalimo; Eeva K. Salminen 📂 Article 📅 2003 🏛 John Wiley and Sons 🌐 English ⚖ 82 KB

## Abstract ## BACKGROUND Two families of tumor suppressor genes, Cip/Kip (p21, p27, and 57) and INK4 (p15, p16, p18, and p19), regulate cell proliferation and neoplastic transformation. p27 exerts its suppressor effect through cyclin E‐dependent kinase (CDK2) by inhibiting the phosphorylation of

A pilot study of cis-diamminedichloropla
A pilot study of cis-diamminedichloroplatinum and radiation therapy in patients with high grade astrocytomas
✍ Lynn G. Feun; David J. Stewart; Moshe Maor; Milam Leavens; Niramol Savaraj; M. A 📂 Article 📅 1983 🏛 Springer US 🌐 English ⚖ 310 KB

A pilot study was performed combining cis-diamminedichloroplatinum (CDDP) and radiation therapy to treat patients with high-grade astrocytomas. CDDP at a dose of 40 mg/m2/week intravenously was given during the course of cranial irradiation. Following irradiation, CDDP was given every three weeks on

A phase I toxicity study of human rDNA i
A phase I toxicity study of human rDNA interferon in patients with solid tumours
✍ J. Wagstaff; G. Chadwick; A. Howell; N. Thatcher; J. H. Scarffe; D. Crowther 📂 Article 📅 1984 🏛 Springer 🌐 English ⚖ 503 KB

This study was designed to evaluate the clinical tolerance to multiple IM injections of rDNA-produced human alpha-2 interferon (IFN) (Schering-Plough 30500) in patients with solid tumours. IFN was administered in escalating IM doses in separate groups of patients daily for 14 days and then twice wee